Your browser doesn't support javascript.
loading
Chinese expert brief consensus on newborn screening of inherited metabolic disorders during the novel coronavirus infection epidemic.
Liu, Shan; Wang, Dongjuan; Wan, Kexing; Liu, Hao; Zhang, Dayong; Yang, Jing; Yuan, Zhaojian; He, Xiaoyan; Wang, Jie; Ou, Mingcai; Zhu, Wenbin; Qu, Yiping; Zhao, Dehua; Wang, Weipeng; Liu, Shiguo; Gu, Maosheng; Huang, Shuodan; Wang, Zhiguo; Zou, Lin.
Afiliação
  • Liu S; Newborn Screening Center/Center for Clinical Molecular Laboratory Medicine, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation Base of Child Development and
  • Wang D; Newborn Screening Center/Center for Clinical Molecular Laboratory Medicine, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation Base of Child Development and
  • Wan K; Newborn Screening Center/Center for Clinical Molecular Laboratory Medicine, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation Base of Child Development and
  • Liu H; Newborn Screening Center/Center for Clinical Molecular Laboratory Medicine, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation Base of Child Development and
  • Zhang D; Newborn Screening Center/Center for Clinical Molecular Laboratory Medicine, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation Base of Child Development and
  • Yang J; Newborn Screening Center/Center for Clinical Molecular Laboratory Medicine, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation Base of Child Development and
  • Yuan Z; Newborn Screening Center/Center for Clinical Molecular Laboratory Medicine, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation Base of Child Development and
  • He X; Newborn Screening Center/Center for Clinical Molecular Laboratory Medicine, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation Base of Child Development and
  • Wang J; Center of Clinical Laboratory, Maternal and Child Health Care Hospital of Hainan Province, Haikou 570000, China.
  • Ou M; Newborn Screening Center of Sichuan, Maternal and Child Health Hospital of Sichuan Province, Chengdu 610000, China.
  • Zhu W; Fujian Neonatal Screening Center, Fujian Maternal and Children Health Hospital, Fuzhou 350000, China.
  • Qu Y; Newborn Screening Center of Zhejiang, Children's Hospital of Zhejiang University School of Medicine, Hangzhou 310000, China.
  • Zhao D; Newborn Screening Center of Henan Maternal and Child Health Hospital, the Third Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China.
  • Wang W; Health Care Department, Maternal and Child Health Hospital of Hubei Province, Wuhan 430000, China.
  • Liu S; Qingdao Women & Children Hospital Neonatal Screening Lab, Qingdao 266000, China.
  • Gu M; Genetic Center of Xuzhou Maternal and Children Health Hospital, Xuzhou 221000, China.
  • Huang S; Meizhou Women & Children Hospital, Meizhou 514000, China.
  • Wang Z; National Center for Clinical Laboratories, Beijing Hospital, National Center for Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100000, China.
  • Zou L; Newborn Screening Center/Center for Clinical Molecular Laboratory Medicine, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation Base of Child Development and
Ann Transl Med ; 8(7): 429, 2020 Apr.
Article em En | MEDLINE | ID: mdl-32395473
ABSTRACT
Novel coronavirus (2019-nCov) infection (COVID-19) rapidly spread across China and 25 countries in the worldwide, which infected not only adults but also children, even neonates. Each year, about 15 million newborns are delivered in China. Newborn screening (NBS) helps effectively prevent some mental retardation, premature death, and adverse outcomes in the early stage of baby, which could detect some inherited metabolic disorders (IMDs). During this COVID-19 epidemic, how to balance the risk of infected 2019-nCov and the risk of disability and teratogenesis of IMDs. Expert members of NBS extra quality assessment in National Clinical Center of Laboratory (NCCL) give a brief consensus for NBS of IMDs in the COVID-2019 epidemic, hoping that the brief consensus could be reference for NBS of IMDs in the other epidemic areas or periods all over the world.
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Revista: Ann Transl Med Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Revista: Ann Transl Med Ano de publicação: 2020 Tipo de documento: Article